Skip to content

Time-differentiated Therapeutic Hypothermia

Time-differentiated Treatment With Mild Therapeutic Hypothermia Following Cardiac Arrest, a Multi Center Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01689077
Acronym
TTH48
Enrollment
355
Registered
2012-09-20
Start date
2013-01-31
Completion date
2017-01-31
Last updated
2017-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Out of Hospital Cardiac Arrest

Brief summary

The purpose of this study is to determine if 48 hours of mild therapeutic hypothermia following out of hospital cardiac arrest gives a better cerebral outcome compared to 24 hours therapeutic hypothermia.

Detailed description

Sudden out-of-hospital cardiac arrest (OOH-CA) remains a significant cause of death. However, in 2002 it was in two clinical trials demonstrated that mild therapeutic hypothermia in comatose OOH-CA victims yields a better cerebral outcome measured by Cerebral Performance Category Score (CPC) after 6 month. The optimal mild hypothermia treatment time is however not known. The two trials from 2002 apply the treatment for 12 and 24 hours respectively. In newborns with cerebral hypoxic damage the standard treatment time is 72 hours. It is therefore relevant to investigate the influence of the treatment time on the cerebral outcome in OOH-CA victims. In the present study cerebral outcome after mild therapeutic hypothermia (target temperature 33 degrees centigrade) in OOH-CA patients for 24 is compared to outcome after 48 hours of mild hypothermia. The main outcome parameter is mortality and CPC score measured 6 month after the treatment.

Interventions

Mild therapeutic hypothermia with a target temperature of 33 degrees Centigrade for 24 or 48 hours

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Out of hospital cardiac arrest of suspected cardiac origin 2. Return of spontaneous circulation (ROSC) 3. Glasgow Coma Score \< 8 4. Estimated time interval from cardiac arrest to ROSC ≤ 60 min

Exclusion criteria

1. OOH-CA of suspected origin other than cardiac 2. In hospital Cardiac arrest 3. Terminal disease 4. Coagulation disorders 5. Unwitnessed asystolia 6. Time from cardiac arrest to start of hypothermia treatment \> 240 min 7. GCS ≥ 8 8. Pregnancy 9. Persistent cardiogenic shock (Systolic blood pressure \< 80 mmHg despite inotropic treatment and aortic balloon pump). 10. CPC 3-4 before cardiac arrest 11. Acute intra cerebral bleeding 12. Acute stroke 13. Acute coronary artery bypass grafting

Design outcomes

Primary

MeasureTime frameDescription
CPC6 monthCPC = Cerebral Performance Category Score. The primary outcome of the study is analyzed as the proportion of patients with good neurological outcome in the two groups, (CPC 1-2) at 6 months after CA.

Secondary

MeasureTime frameDescription
Adverse events10 daysAdverse events are registered during the treatment and until discharge from primary hospital unit
CPC at discharge3 monthCPC at discharge from primary hospital unit and after 28 days plus after 3 month
Mortality6 monthCPC 5 at 6 month

Other

MeasureTime frameDescription
GCS28 daysGlasgow Coma Score at day 4 and at discharge from primary hospital unit
GCS progression25 weeksGlasgow Coma Score throughout the observation period

Countries

Belgium, Denmark, Estonia, Finland, Germany, Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026